Art

J-GLOBAL ID：201102225966226961   Reference number：11A1109818

Antithrombotic Therapy in Atrial Fibrillation - Evaluation and Positioning of New Oral Anticoagulant Agents -

心房細動における抗血栓療法 新規経口抗凝固薬の評価と位置付け

Author (24)： OGAWA Satoshi (Mita Hospital, International Univ. of Health and Welfare) ,  OGAWA Satoshi ,  KORETSUNE Yukihiro (Inst. for Clinical Res., Osaka National Hospital) ,  KORETSUNE Yukihiro ,  YASAKA Masahiro (Dep. of Cerebrovascular Medicine, National Hospital Organization, Kyushu Medical Center) ,  YASAKA Masahiro ,  AIZAWA Yoshifusa (Niigata Univ. Graduate school of Medical and Dental Sci. Cardiology) ,  AIZAWA Yoshifusa ,  ATARASHI Hirotsugu (Dep. of Internal Medicine and Cardiology, Nippon Medical School, Tama-Nagayama Hospital) ,  ATARASHI Hirotsugu ,  INOUE Hiroshi (The Second Dep. of Internal Medicine, Univ. of Toyama, Graduate School of Medicine) ,  INOUE Hiroshi ,  KAMAKURA Shiro (Div. of Arrhythmia and Electrophysiology, Dep. of Cardiovascular Medicine, National Cerebral and Cardiovascular Center) ,  KAMAKURA Shiro ,  KUMAGAI Koichiro (Heart Rhythm Center, Fukuoka Sanno Hospital) ,  KUMAGAI Koichiro ,  MITAMURA Hideo (Cardiovascular Dep., Saiseikai Central Hospital) ,  MITAMURA Hideo ,  OKUMURA Ken (Cardiology, Respiratory Medicine and Nephrology, Hirosaki Univ. Graduate School of Medicine) ,  OKUMURA Ken ,  SUGI Kaoru (Div. of Cardiovascular Medicine, Toho Univ., Ohashi Hospital) ,  SUGI Kaoru ,  YAMASHITA Takeshi (The Cardiovascular Inst.) ,  YAMASHITA Takeshi
Material： Circulation Journal  (Circ J)
Volume： 75  Issue： 7  Page： 1539-1547 (J-STAGE)  Publication year： 2011 
JST Material Number： F0908A  ISSN： 1346-9843  Document type： Article
Article type： 文献レビュー  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *auricular fibrillation ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=11A1109818&from=J-GLOBAL&jstjournalNo=F0908A") }}

JST classification (1)： Drug therapy(=pharmacotherapy)for cardiovascular system diseases  (GJ05020M)

Substance index (2)： Dabigatran ,  Warfarin potassium

Reference (59)：

• 1. Schirmer SH, Baumhäkel M, Neuberger HR, Hohnloser SH, van Gelder IC, Lip GY, et al. Novel anticoagulants for stroke prevention in atrial fibrillation: Current clinical evidence and future developments. J Am Coll Cardiol 2010; 56: 2067-2076.
• 2. Writing Group Members, Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, et al. Heart disease and stroke statistics-2010 update: A report from the American Heart Association. Circulation 2010; 121: e46-e215.
• 3. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation: Analysis and implications. Arch Intern Med 1995; 155: 469-473.
• 4. JCS Joint Working Group. Guidelines for pharmacotherapy of atrial fibrillation (JCS 2008): Digest version. Circ J 2010; 74: 2479-2500.
• 5. Ohsawa M, Okayama A, Sakata K, Kato K, Itai K, Onoda T, et al. Rapid increase in estimated number of persons with atrial fibrillation in Japan: An analysis from national surveys on cardiovascular diseases in 1980, 1990 and 2000. J Epidemiol 2005; 15: 194-196.

Terms in the title (4)： 心房細動 ,  抗血栓療法 ,  新規経口抗凝固薬 ,  評価